Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,208
Sort by:

Wasting syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wasting syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understan...

January 2022 200 pages

WEE1 protein inhibitors - Pipeline Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “WEE1 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeli...

January 2022 60 pages

Wegener Vasculitis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wegener Vasculitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...

January 2022 60 pages

Wegener's Granulomatosis/Granulomatosis with Polyangiitis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wegener's Granulomatosis/Granulomatosis with Polyangiitis - Epidemiology Forecast to 2032' report delivers an in-...

January 2022 60 pages

Wegener's Granulomatosis/Granulomatosis with Polyangiitis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wegener's Granulomatosis/Granulomatosis with Polyangiitis- Market Insights, Epidemiology, and Market Forecast-20...

January 2022 200 pages

Weight Loss/Weight Management (Obesity) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Weight Loss/Weight Management (Obesity) - Epidemiology Forecast to 2032' report delivers an in-depth understandin...

January 2022 60 pages

Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Weight Loss/Weight Management (Obesity)- Market Insights, Epidemiology, and Market Forecast-2032' report deliver...

January 2022 200 pages

West Nile Encephalitis - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'West Nile Encephalitis- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth und...

January 2022 200 pages

West Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'West Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understandin...

January 2022 200 pages

Wet Age-Related Macular Degeneration (Wet AMD) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wet Age-Related Macular Degeneration (Wet AMD) - Epidemiology Forecast to 2032' report delivers an in-depth under...

January 2022 60 pages

Wet Age-Related Macular Degeneration (Wet AMD) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wet Age-Related Macular Degeneration (Wet AMD)- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Whooping cough/Pertussis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Whooping cough/Pertussis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...

January 2022 60 pages

Wide Neck Bifurcation Intracranial Aneurysms - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wide Neck Bifurcation Intracranial Aneurysms - Epidemiology Forecast to 2032' report delivers an in-depth underst...

January 2022 60 pages

Wide Neck Bifurcation Intracranial Aneurysms - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wide Neck Bifurcation Intracranial Aneurysms- Market Insights, Epidemiology, and Market Forecast-2032' report de...

January 2022 200 pages

Wilms Tumor - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wilms Tumor - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...

January 2022 60 pages

Wilms Tumor - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wilms Tumor- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding...

January 2022 200 pages

Wiskott-Aldrich Syndrome - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Wiskott-Aldrich Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...

January 2022 60 pages

Wiskott-aldrich Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Wiskott-aldrich Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth u...

January 2022 200 pages

X Linked Hypophosphatemia - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'X Linked Hypophosphatemia- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

X-Linked Myotubular Myopathy (XLMTM) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'X-Linked Myotubular Myopathy (XLMTM) - Epidemiology Forecast to 2032' report delivers an in-depth understanding o...

January 2022 60 pages

X-Linked Myotubular Myopathy (XLMTM) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'X-Linked Myotubular Myopathy (XLMTM)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers a...

January 2022 200 pages

X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology forecast- 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast to 2032' report delivers an in-depth understanding o...

January 2022 60 pages

Xlinked hypophosphatemia (XLH) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Xlinked hypophosphatemia (XLH) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Xlinked hypophosphatemia (XLH) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Xlinked hypophosphatemia (XLH)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032' report delivers an in-depth unde...

January 2022 60 pages

Xlinked Severe Combined Immunodeficiency (SCID) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Xlinked Severe Combined Immunodeficiency (SCID)- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Yellow Fever - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Yellow Fever - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Yellow Fever - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Yellow Fever- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding...

January 2022 200 pages

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Zollinger Ellison Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Zollinger-Ellison Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Zollinger-Ellison Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Global Active Pharmaceutical Ingredient (API) Market – Analysis By Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), By Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

US$ 2,400.00

Executive The global Active Pharmaceutical Ingredients (API) Market was valued at USD 179.6 Billion in the year 2020. Growth opportunities for the Active Pharmaceutical Ingredient market is attributed...

December 2021 230 pages

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute M...

December 2021 4011 pages

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

US$ 2,500.00

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degenerati...

December 2021 1196 pages

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021

US$ 3,500.00

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Alpha 2C Adr...

December 2021 55 pages

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021

US$ 3,500.00

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC...

December 2021 62 pages

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocar...

December 2021 2359 pages

Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Int...

December 2021 335 pages

Colon Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Colon Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Drugs In Development, 2021, provides an...

December 2021 1498 pages

Dengue Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Dengue Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever – Drugs In Development, 2021, pr...

December 2021 203 pages

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis –...

December 2021 44 pages

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathie...

December 2021 96 pages

Female Contraception (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Contraception (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Drugs In...

December 2021 128 pages

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction –...

December 2021 90 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipe...

December 2021 88 pages

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Drugs...

December 2021 3486 pages

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy – Drugs In Develo...

December 2021 117 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcar...

December 2021 45 pages

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia – Drugs In Development, 2021,...

December 2021 34 pages

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia – Drugs In Development,...

December 2021 85 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosph...

December 2021 75 pages

Filters

Search

Categories

152
14,608
11,952
339
73
1,084

Publishers

72
1
1,760
342
469
292
33
4
1,887
635
92
3,251
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,602

Price

—

Date

—

Pages

—

Offers

44
5
1